Quest Diagnostics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Quest Diagnostics Inc's inventory turnover ratio sequentially decreased to 37.13 in the second quarter 2026, unsurprisingly, as the Quest Diagnostics Inc markets continue to deteriorate, and DGX's faces growing challenges to bring down its inventories. Average processing period, for Quest Diagnostics Inc's inventories remained unchanged at 10 days, in the Jun 30 2026 quarter.

Within Healthcare sector 4 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 9.

DGX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Quest Diagnostics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DGX Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	24.6 %	19.05 %	0.53 %	1.09 %	2.75 %
Y / Y Cost of Sales Growth	10.89 %	9.17 %	7.54 %	11.33 %	14.12 %
Inventory Turnover Ratio (TTM)	37.13	38.29	39.25	38.6	37.68
DGX's Total Ranking	# 9	# 9	# 62	# 31	# 52
Average inventory processing period	10	10	9	9	10
Seq. Inventory Growth	3.56 %	19.05 %	1.61 %	-0.53 %	-1.06 %
Seq. Cost of Sales Growth	3.23 %	3.01 %	1.55 %	2.7 %	1.62 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 1
Healthcare Sector	# 5
Overall Market	# 9

Inventory Turnover Ratio Statistics
High	Average	Low
58.33	44.61	30.61
(June 30. 2011)		(Jun 30 2021)

DGX Company Profile >> Back to DGX Efficiency Comparisons >> Compare DGX Inventory Turnover Ratio to its Competitors

Financial Statements
Quest Diagnostics Inc's Inventories	$ 233 Millions	Visit DGX's Balance sheet
Quest Diagnostics Inc's Cost of Revenues TTM	$ 7,732 Millions	Visit DGX's Income Statement
What are DGX's Sales?		Visit DGX's Sales by Segment

Other Inventory Turnover Ratios
Quest Diagnostics Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DGX's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DGX's Competitors
Inventory Turnover Ratio for DGX's Suppliers
Inventory Turnover Ratio for DGX's Customers

You may also want to know
DGX's Sales Growth Rates	DGX's Pe Price to earnings ratio	DGX's Receivables Turnover Ratio	DGX's Stock Quote
DGX's Net Income Growth Rates	DGX's Ps Price to Sales ratio	DGX's Sales per Employee	DGX's Asset Turnover Ratio
DGX's Net Margin	DGX's Pb Price to Book ratio	DGX's Financial Strength Ratios	DGX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Harmony Biosciences Holdings inc	39.56	$ 236.198 Millions	$ 6 Millions
Qhslab Inc	39.48	$ 0.975 Millions	$ 0 Millions
Quest Diagnostics Inc	37.13	$ 7,732.000 Millions	$ 208 Millions
Vaso Corporation	33.32	$ 28.238 Millions	$ 1 Millions
Omada Health Inc	24.96	$ 97.232 Millions	$ 4 Millions
Aspira Women s Health inc	22.57	$ 5.988 Millions	$ 0 Millions
Prophase Labs Inc	22.13	$ 2.633 Millions	$ 0 Millions
Lucid Diagnostics Inc	21.74	$ 9.740 Millions	$ 0 Millions
Sbc Medical Group Holdings Incorporated	19.68	$ 48.095 Millions	$ 2 Millions
Adapthealth Corp	18.95	$ 2,676.899 Millions	$ 141 Millions
Precipio inc	18.05	$ 15.200 Millions	$ 1 Millions
Rockwell Medical inc	17.36	$ 57.537 Millions	$ 3 Millions
Neuronetics Inc	16.61	$ 78.345 Millions	$ 5 Millions
Rosecliff Acquisition Corp I	14.94	$ 9.597 Millions	$ 1 Millions
Catheter Precision Inc	14.83	$ 1.001 Millions	$ 0 Millions
Agape Atp Corporation	14.52	$ 0.413 Millions	$ 0 Millions
Edap Tms Sa	12.79	$ 62.351 Millions	$ 5 Millions
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Irhythm Holdings Inc	10.79	$ 235.967 Millions	$ 22 Millions
Tarsus Pharmaceuticals Inc	10.20	$ 43.740 Millions	$ 4 Millions
Lantheus Holdings Inc	10.09	$ 619.325 Millions	$ 61 Millions
Sotera Health Company	10.04	$ 547.412 Millions	$ 55 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions

Date modified: 2026-09-08T17:24:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.